StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BTTC

Black Titan Corporation

BTTC Nasdaq Services-Computer Programming Services EDGAR ↗
$0.46
+0.03 +6.68%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$3.58M
Revenue (TTM) ⓘ
—
Net income (TTM) ⓘ
-$163K
EPS (TTM) ⓘ
$-163,173.00
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
—
Cash ⓘ
—
Total assets ⓘ
—
Gross margin ⓘ
—
52-week range ⓘ
$0.34 – $39.00

AI briefing

from the latest 10-K, 10-Q and 8-K events

Black Titan Corporation is a Cayman Islands-incorporated holding company that became a Nasdaq-listed operating business through an October 1, 2025 business combination with Malaysia-based TalenTec Sdn. Bhd.

What they do

Black Titan Corporation is the public parent of TalenTec Sdn. Bhd., a Malaysia private limited company, and TalenTec's subsidiary KEDA Pte Ltd. The company was formed as a vehicle to combine with TalenTec and list on Nasdaq. The business combination closed on October 1, 2025, and the company's ordinary shares trade on the Nasdaq Capital Market under the symbol BTTC.

Revenue drivers

  • TalenTec Sdn. Bhd. — The Malaysia-based operating company that became the company's principal business upon closing of the business combination on October 1, 2025.
  • KEDA Pte Ltd. — A subsidiary of TalenTec Sdn. Bhd., included in the Company Group as described in the filing.

Recent performance

The XBRL data provided reports a net loss of $163,173 for fiscal 2025, with operating cash flow of negative $143,173. The latest balance sheet, as of July 31, 2025, shows total liabilities of $167,120 and shareholder equity of negative $167,120. Diluted EPS is shown as $-163,173 for fiscal 2025 in the provided data, a figure that appears inconsistent with per-share reporting conventions. The filing does not provide revenue figures or segment-level results in the excerpts provided. No comparative prior-year figures are included in the provided data.

Strategy

The stated direction is to operate as a Nasdaq-listed company following completion of the business combination on October 1, 2025. The transaction combined PubCo, Merger Sub, and TalenTec, with Merger Sub merging into Titan Pharmaceuticals, Inc. and TalenTec shareholders contributing their shares to PubCo. The company entered into ancillary agreements including a registration rights agreement dated October 1, 2025, covering Mr. Dass and certain holders. The filing describes the Company Group as TalenTec Sdn. Bhd. and, as context requires, its subsidiary KEDA Pte Ltd.

Risks

  • Negative shareholder equity — As of July 31, 2025, shareholder equity was negative $167,120 against total liabilities of $167,120.
  • Operating cash outflows — Operating cash flow was negative $143,173 for fiscal 2025.
  • Recent business combination integration — The business combination closed only on October 1, 2025, so the company has limited history as a combined public entity.
  • Non-accelerated filer status — The filing designates the registrant as a non-accelerated filer, consistent with its smaller reporting profile.

Outlook

The filing excerpts provided do not include management's forward outlook or guidance. The company's reporting is for the fiscal year ended July 31, 2025, prior to the October 1, 2025 closing of the business combination. No revenue, margin, or growth expectations are stated in the provided material.